Liver Failure
-
Subject Areas on Research
- A prognostic model for patients with end-stage liver disease.
- A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis.
- A20 protects mice from lethal radical hepatectomy by promoting hepatocyte proliferation via a p21waf1-dependent mechanism.
- Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks.
- Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study.
- Bile acids in xenogeneic ex-vivo liver perfusion: function of xenoperfused livers and compatibility with human bile salts and porcine livers.
- CYP7B1: one cytochrome P450, two human genetic diseases, and multiple physiological functions.
- Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
- Death and liver transplantation within 2 years of onset of drug-induced liver injury.
- Death of a living liver donor from illicit drugs.
- Defining long-term outcomes with living donor liver transplantation in North America.
- Depressive symptoms and mortality in lung transplant.
- Developmental Morphogens & Recovery from Alcoholic Liver Disease.
- Disparities in liver transplantation before and after introduction of the MELD score.
- Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index.
- Effect of surgical and spontaneous portasystemic shunts on liver transplantation.
- Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.
- Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.
- Fulminant hepatic failure due to disseminated adenovirus infection in a patient with chronic lymphocytic leukemia.
- Fulminant hepatic failure due to herpes simplex after hysteroscopy.
- Helicobacter canis bacteremia in a patient with fever of unknown origin.
- Hepatic failure after rectal acetaminophen.
- Hepatitis C.
- Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
- Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5.
- Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF).
- Improvement in survival associated with adult-to-adult living donor liver transplantation.
- In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats.
- Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome.
- Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome.
- Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease.
- Kinetics of hepatitis C virus reinfection after liver transplantation.
- Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation.
- Liver and intestine transplantation in the United States, 1997-2006.
- Liver and small bowel transplantation: therapeutic alternatives for the treatment of liver disease and intestinal failure.
- Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia.
- Liver transplantation for alcoholic liver disease.
- Liver transplantation from a cadaver donor with ethylene-glycol-induced brain death.
- Management of gastrointestinal bleeding in patients with cirrhosis.
- Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients.
- Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
- Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion.
- National survey of adult transplant hepatologists on the pediatric-to-adult care transition after liver transplantation.
- One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy.
- Planned right ventricular support for combined heart-liver transplantation.
- Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.
- Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.
- Postpartum hemorrhage: when uterotonics and sutures fail.
- Predictive indices of morbidity and mortality after liver resection.
- Pretransplant predictors of recovery of renal function after liver transplantation.
- Pretransplant status and patient survival following liver transplantation.
- Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes.
- Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.
- Rescue of a living donor with liver transplantation.
- Reversible nefazodone-induced liver failure.
- Reversible retinal edema in an infant with neonatal hemochromatosis and liver failure.
- Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
- Survival after adult liver transplantation does not correlate with transplant center case volume in the MELD era.
- Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
- The clinical relevance of alloantibody in liver transplantation.
- The coagulation cascade in cirrhosis.
- The humoral immune response in humans following cross-perfusion of porcine organs.
- The role of liver transplantation in the management of portal hypertension.
- The spectrum of complications following left ventricular assist device placement.
- Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
- Use of remifentanil in infants.
- Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
- Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.